Intellia Therapeutics (NTLA) Net Margin Growth (3y) (2018 - 2026)
Intellia Therapeutics (NTLA) Net Margin Growth (3y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
49,253.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
506.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Intellia Therapeutics |
1.86 Bn |
1.86 Bn |
- |
15,961.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
15,961.00 |
| Dec 31, 2025 |
37,091.00 |
| Sep 30, 2025 |
2,069.00 |
| Jun 30, 2025 |
-2,457.00 |
| Mar 31, 2025 |
60,233.00 |
| Dec 31, 2024 |
-35,560.00 |
| Sep 30, 2024 |
2.24 Mn |
| Jun 30, 2024 |
-76,958.00 |
| Mar 31, 2024 |
36,657.00 |
| Dec 31, 2023 |
728,728.00 |
| Sep 30, 2023 |
-86,176.00 |
| Jun 30, 2023 |
-68,121.00 |
| Mar 31, 2023 |
-15,698.00 |
| Dec 31, 2022 |
-51,307.00 |
| Sep 30, 2022 |
-55,820.00 |
| Jun 30, 2022 |
-46,463.00 |
| Mar 31, 2022 |
-106,687.00 |
| Dec 31, 2021 |
-37,974.00 |
| Sep 30, 2021 |
-2.36 Mn |
| Jun 30, 2021 |
-76,105.00 |
